Impacts of Recombinant Human Erythropoietin Treatment During Predialysis Periods on the Progression of Chronic Kidney Disease in a Large-Scale Cohort Study (Co-JET study)-Reference-Cited by-同舟云学术

Impacts of Recombinant Human Erythropoietin Treatment During Predialysis Periods on the Progression of Chronic Kidney Disease in a Large-Scale Cohort Study (Co-JET study)

Published:2013-08-27 Issue:2 Volume:18 Page:140-148
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Akizawa Tadao¹,Saito Akira²,Gejyo Fumitake³,Suzuki Masashi⁴,Nishizawa Yoshiki⁵,Tomino Yasuhiko⁶,Tsubakihara Yoshiharu⁷,Akiba Takashi⁸,Hirakata Hideki⁹,Watanabe Yuzo¹⁰,Kawanishi Hideki¹¹,Bessho Masami¹²,Udagawa Yukio¹³,Aoki Kotonari¹³,Uemura Yukari¹⁴,Ohashi Yasuo¹⁴,

Affiliation:

1. Division of Nephrology; Department of Medicine; Showa University School of Medicine; Tokyo Japan

2. Yokohama Daiichi Hospital; Yokohama Japan

3. Niigata University Graduate School of Medical and Dental Sciences; Niigata Japan

4. Shinraku-en Hospital; Niigata Japan

5. Osaka City University Graduate School of Medicine; Osaka Japan

6. Division of Nephrology; Department of Internal Medicine; Juntendo University Faculty of Medicine; Tokyo Japan

7. Department of Comprehensive Kidney Disease Research; Osaka University Graduate School of Medicine; Osaka Japan

8. Department of Blood Purification; Kidney Center; Tokyo Women's Medical University; Tokyo Japan

9. Department of Nephrology; Fukuoka Red Cross Hospital; Fukuoka Japan

10. Department of Internal Medicine; Kasugai Municipal Hospital; Nagoya Japan

11. Department of Artificial Organs; Tsuchiya General Hospital; Hiroshima Japan

12. Department of Hematology; Saitama Medical School; Saitama Japan

13. Pharmacovigilance Department; Chugai Pharmaceutical Co., Ltd.; Tokyo Japan

14. Department of Biostatistics, School of Public Health; The University of Tokyo; Tokyo Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Reference22 articles.

1. Overview of regular dialysis treatment in Japan (as of 31 December 2009);Nakai;Ther Apher Dial,2012

2. Identification of persons at high risk for kidney disease via targeted screening: the NKF Kidney Early Evaluation Program;Brown;Kidney Int Suppl,2003

3. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N Engl J Med,2004

4. Chronic kidney disease and cardiovascular disease in general Japanese population: Hisayama Study;Ninomiya;Kidney Int,2005

5. The cardio-renal anaemia syndrome: does it exist?;Silverberg;Nephrol Dial Transplant,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease;Frontiers in Immunology;2023-09-21

2. Prolonged Duration of Erythropoiesis-Stimulating Agents’ Action Delays Disease Progression in Anti-Thy 1 Antibody-Induced Chronic Glomerulonephritis Rats;Pharmacology;2020-08-21

3. Correlation between haemoglobin level and type of erythropoiesis-stimulating agent at initiation of haemodialysis;International Journal of Clinical Pharmacy;2020-02-06

4. Haemoglobin concentration and survival of haemodialysis patients before and after experiencing cardiovascular disease: a cohort study from Japanese dialysis outcomes and practice pattern study (J-DOPPS);BMJ Open;2019-09

5. Effect of carbamylated erythropoietin on neuronal apoptosis in fetal rats during intrauterine hypoxic-ischemic encephalopathy;Biological Research;2019-05-13